Immuron Successfully Completes NASH Phase II Clinical Study Milestone
November 09, 2017 09:00 ET
|
Immuron Limited
MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ:IMRN), an Australian microbiome biopharmaceutical company focused on developing and commercialising oral...
Blake Insomnia Therapeutics Inc. Announces Submitting Clinical Trial Application for Phase II Clinical Testing
August 25, 2017 09:30 ET
|
Blake Insomnia Therapeutics, Inc.
NEW YORK, Aug. 25, 2017 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics Inc. (OTCQB:BKIT), a New York based pharmaceutical company devoted to improving quality of life for people with insomnia, is...
ISR Projects Continued Growth Propelling the CRO Market Forward
February 02, 2016 11:56 ET
|
Industry Standard Research
CARY, NC--(Marketwired - February 02, 2016) - Industry Standard Research (ISR) today announced a new addition to its Market Analysis suite of reports. The "2016 Edition of the CRO Market Size...
Accenture, ICON Among Providers Shortlisted in ISR's 7th Annual CRO Quality Benchmarking Study
May 06, 2015 11:49 ET
|
Industry Standard Research
CARY, NC--(Marketwired - May 06, 2015) - Industry Standard Research (ISR) has announced the availability of its 7th annual CRO Quality Benchmarking series with the release of its "CRO Quality...